Join the Family Office Networks’ Webinar Series featuring Psy Therapeutics, Inc.
PSY Therapeutics, Inc. is an emerging biopharmaceutical company focused on developing transformative medicines to treat serious neurodegenerative and neuropsychiatric disorders. The Company’s novel approach to customized small molecule drug discovery and development combines cutting-edge technology with an extensive network of collaborators to drive R&D innovation and productivity.
In this webinar, the PSY team will focus on their unique tau program for disease-modifying treatment of Alzheimer’s Disease (AD) and related tauopathies. They will take a deeper look at the growing patient population, assess lessons learned from other AD program failures and detail Psy’s opportunity for a new approach to disease treatment.